Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Accepts healthy volunteers Results available

Main Study: A Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Study to Evaluate the Analysis of Mammograms Following Treatment for Correction of Wrinkles in Décolletage Area in the Investigational Study 43USRV1906

ClinicalTrials.gov ID: NCT04717934

Public ClinicalTrials.gov record NCT04717934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Main Study: A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Sub-study to Assess Interpretation of Mammograms Following Treatment for Correction of Wrinkles in the Décolletage Area in the Investigational Study 43USRV1906

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Main study: Randomized, evaluator-blinded, no treatment controlled multicenter study to evaluate safety and effectiveness of GAL1906 for the correction of wrinkles in the décolletage area. Sub-study: To evaluate imaging interpretation of mammograms in subjects who were enrolled and treated in the 43USRV1906 main study. The sub-study will determine if hyaluronic acid injections in the décolletage interfere with diagnosis or interpretation of mammogram results.

Study identification

NCT ID
NCT04717934
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Galderma R&D
Industry
Enrollment
211 participants

Conditions and interventions

Conditions

Interventions

Device

Eligibility (public fields only)

Age range
22 Years and older
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 8, 2021 (Actual)
Primary completion
May 26, 2025 (Actual)
Completion
Jun 13, 2025 (Actual)
Last update posted
Jul 15, 2026

2021 – 2025

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
14
Facility City State ZIP Site status
Galderma Research Site Birmingham Alabama 35209 —
Galderma Research Site Scottsdale Arizona 85255 —
Galderma Research Site Redondo Beach California 90277 —
Galderma Research Site San Diego California 92121 —
Galderma Research Site Vista California 92083 —
Galderma Research Site Westport Connecticut 06880 —
Galderma Research Site Boynton Beach Florida 33472 —
Galderma Research Site Coral Gables Florida 33146 —
Galderma Research Site Alpharetta Georgia 30022 —
Galderma Research Site Chicago Illinois 60654 —
Galderma Research Site Baltimore Maryland 21208 —
Galderma Research Site New York New York 10021 —
Galderma Research Site Spring Texas 77388 —
Galderma Research Site Mequon Wisconsin 53092 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04717934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 15, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04717934 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →